Gabriel Brooks

Gabriel Brooks currently serves as the Chief Medical Officer at Solid Biosciences, focusing on the company's transition to a platform gene therapy organization with a diverse pipeline in neuromuscular and cardiac programs. Prior to this role, Brooks held the position of Executive Director at Pfizer, and served as Vice President of Research and Development at 4D Molecular Therapeutics, where responsibilities included leading medical projects on gene therapies for various diseases. Brooks has extensive experience in clinical research and development, including roles at General Electric Healthcare, Gilead Sciences, and UCSF, where contributions spanned clinical management, strategic planning, and cardiology. Education includes a Doctor of Medicine from Weill Cornell Medical College and a Master's degree in Biostatistics Epidemiology from the University of California, San Francisco.